Delivery Order SPE2DB24D2105-SPE2DB24FANWL
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, with a ceiling value of $6,087.80, is a firm fixed price delivery order for the supply of Cosentyx Unoready 300 mg pens. The contract has a performance period through May 3, 2024. Amerisourcebergen Drug Corp, through its Corporate...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $11,504.50 firm fixed price delivery order is for the supply of Cosentyx 300 mg dose-2 prefilled syringes. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,071.56, is a delivery order for the drug Cosentyx Sensoready 150 mg pen. The contract has a firm fixed price and an ultimate completion date of November 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides the Defense Logistics Agency (DLA) Troop Support Medical with delivery orders for Cosentyx 300 mg dose-2 pens. The $4,463.02 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as a primary vehicle for Amerisourcebergen to deliver a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $52,495.91 firm fixed-price contract is for the supply of Cosentyx Sensoready 150 mg pens, a specialty pharmaceutical product. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a wide...
- This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply Cosentyx Sensoready 150 mg pens to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract. The award has a ceiling value of $19,470.16 and an ultimate completion date of April 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the supply of the pharmaceutical product Cosentyx (300mg dose) to the U.S. government. The firm-fixed-price delivery order, valued at $13,697.55, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,293.00 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply the pharmaceutical product Cosentyx SNRDY 300MG DOSE-2PENML. This order is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of COSENTYX SENSOREADY 150 MG PEN medication. The contract, valued at $2,392.79, is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency within the Department of Defense. The contract has a firm fixed-price pricing type and an ultimate completion date of November 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,650.03, is a Delivery Order for Cosentyx 300 mg dose-2 syringes. The contract has an ultimate completion date of April 17, 2023 and is a Firm Fixed Price agreement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB24FANWLDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $56,230.77 fixed-price delivery order is for the supply of Cosentyx Sensoready 150 mg pens. The contract has no set-aside designation and is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. Amerisourcebergen Drug Corp is an experienced prime contractor for the DLA, having received numerous awards to supply a wide range of pharmaceuticals, medical materials, and related distribution services in support of military treatment programs and facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $56.2k | 3/12/24 |